Skip to main content
Clinical and Experimental Immunology logoLink to Clinical and Experimental Immunology
. 1990 Feb;79(2):266–272. doi: 10.1111/j.1365-2249.1990.tb05189.x

The effect of cyclosporin A on the interstitial mononuclear cell infiltration and the induction of Heymann's nephritis.

C Grönhagen-Riska 1, E von Willebrand 1, T Tikkanen 1, E Honkanen 1, A Miettinen 1, H Holthöfer 1, T Törnroth 1
PMCID: PMC1534753  PMID: 2311304

Abstract

Heymann's nephritis was induced with brush-border (BB) antigen. Interstitial mononuclear cell infiltration was studied with cytological examinations of fine-needle aspiration biopsies (FNAB), and with immunoperoxidase stains of frozen sections with monoclonal antisera. The effect of cyclosporin A (CyA), 20 mg/kg when administered intraperitoneally for 8 days in association with both initial immunization, and with the booster 4 weeks later, on the interstitial leukocyte infiltration and on the development of membranous glomerulonephritis (MGN) and proteinuria were investigated. Another group of rats was immunized, but not given CyA. Experimental animals were killed in groups 3, 6 and 20 weeks after initial immunization. CyA inhibited significantly the initial interstitial lymphocyte and blast cell response at 3 weeks (FNAB), but did not inhibit the secondary response after the booster. The anti-BB titre reacted in a similar fashion. Immunoperoxidase stains indicated a clearly suppressed T suppressor/cytolytic (T s/c) cell response. Glomerular basement membrane (GBM) deposits of IgG developed more slowly and were more scarce in the CyA-treated rats, when compared with the untreated group. Only one out of 15 CyA treated rats developed C3 deposits in the GBM during the course of the study, and none developed proteinuria, when most untreated rats (10/17) had C3 deposits and were nephrotic at 20 weeks. Thus, CyA depressed the initial interstitial cellular response after immunization with BB antigen, and also inhibited the development of antibody response, C3 deposits and proteinuria of Heymann nephritis. These effects of CyA may be contributed to an inhibited amplification of the autoimmune response associated with interstitial damage and continuous release of autoantigen.

Full text

PDF
266

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Bannister K. M., Ulich T. R., Wilson C. B. Induction, characterization, and cell transfer of autoimmune tubulointerstitial nephritis. Kidney Int. 1987 Nov;32(5):642–651. doi: 10.1038/ki.1987.256. [DOI] [PubMed] [Google Scholar]
  2. Barabas A. Z., Cornish J., Lannigan R. Stimulation of circulating autoantibody levels in the rat with established progressive passive Heymann nephritis. Clin Exp Immunol. 1986 Jul;65(1):34–41. [PMC free article] [PubMed] [Google Scholar]
  3. Baran D., Vendeville B., Vial M. C., Cosson C., Bascou C., Teychenne P., Druet P. Effect of cyclosporine A on mercury-induced autoimmune glomerulonephritis in the Brown Norway rat. Clin Nephrol. 1986;25 (Suppl 1):S175–S180. [PubMed] [Google Scholar]
  4. Bolton C., Allsopp G., Cuzner M. L. The effect of cyclosporin A on the adoptive transfer of experimental allergic encephalomyelitis in the Lewis rat. Clin Exp Immunol. 1982 Jan;47(1):127–132. [PMC free article] [PubMed] [Google Scholar]
  5. Grönhagen-Riska C., Honkanen E., von Willebrand E., Tikkanen I., Miettinen A., Holthöfer H., Törnroth T. Interstitial mononuclear cell infiltration in Heymann nephritis. Clin Exp Immunol. 1987 Nov;70(2):425–433. [PMC free article] [PubMed] [Google Scholar]
  6. Häyry P., von Willebrand E. Practical guidelines for fine needle aspiration biopsy of human renal allografts. Ann Clin Res. 1981;13(4-5):288–306. [PubMed] [Google Scholar]
  7. Kaibara N., Hotokebuchi T., Takagishi K., Katsuki I. Paradoxical effects of cyclosporin A on collagen arthritis in rats. J Exp Med. 1983 Dec 1;158(6):2007–2015. doi: 10.1084/jem.158.6.2007. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. LOWRY O. H., ROSEBROUGH N. J., FARR A. L., RANDALL R. J. Protein measurement with the Folin phenol reagent. J Biol Chem. 1951 Nov;193(1):265–275. [PubMed] [Google Scholar]
  9. Lai K. N., Lai F. M., Li P. K., Vallance-Owen J. Cyclosporin treatment of IgA nephropathy: a short term controlled trial. Br Med J (Clin Res Ed) 1987 Nov 7;295(6607):1165–1168. doi: 10.1136/bmj.295.6607.1165. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Laupacis A., Stiller C. R., Gardell C., Keown P., Dupre J., Wallace A. C., Thibert P. Cyclosporin prevents diabetes in BB Wistar rats. Lancet. 1983 Jan 1;1(8314-5):10–12. doi: 10.1016/s0140-6736(83)91558-1. [DOI] [PubMed] [Google Scholar]
  11. Nussenblatt R. B., Rodrigues M. M., Salinas-Carmona M. C., Gery I., Cevario S., Wacker W. Modulation of experimental autoimmune uveitis with cyclosporin A. Arch Ophthalmol. 1982 Jul;100(7):1146–1149. doi: 10.1001/archopht.1982.01030040124022. [DOI] [PubMed] [Google Scholar]
  12. Shevach E. M. The effects of cyclosporin A on the immune system. Annu Rev Immunol. 1985;3:397–423. doi: 10.1146/annurev.iy.03.040185.002145. [DOI] [PubMed] [Google Scholar]
  13. Shih W., Hines W. H., Neilson E. G. Effects of cyclosporin A on the development of immune-mediated interstitial nephritis. Kidney Int. 1988 Jun;33(6):1113–1118. doi: 10.1038/ki.1988.119. [DOI] [PubMed] [Google Scholar]
  14. Tejani A. T., Butt K., Trachtman H., Suthanthiran M., Rosenthal C. J., Khawar M. R. Cyclosporine A induced remission of relapsing nephrotic syndrome in children. Kidney Int. 1988 Mar;33(3):729–734. doi: 10.1038/ki.1988.59. [DOI] [PubMed] [Google Scholar]
  15. Thaiss F., Mihatsch M. J., Batsford S., Vogt A., Schollmeyer P. Effect of cyclosporine on in situ immune complex glomerulonephritis. Clin Nephrol. 1986;25 (Suppl 1):S181–S185. [PubMed] [Google Scholar]
  16. von Willebrand E. Fine-needle aspiration cytology of human renal transplants. Clin Immunol Immunopathol. 1980 Nov;17(3):309–322. doi: 10.1016/0090-1229(80)90102-6. [DOI] [PubMed] [Google Scholar]
  17. von Willebrand E. Fine-needle aspiration cytology of human renal transplants. Clin Immunol Immunopathol. 1980 Nov;17(3):309–322. doi: 10.1016/0090-1229(80)90102-6. [DOI] [PubMed] [Google Scholar]

Articles from Clinical and Experimental Immunology are provided here courtesy of British Society for Immunology

RESOURCES